Estimating the economic burden of racial health inequalities in the United States

International Journal of Health Services

Volumn 41, Issue 2, 2011, Pages 231-238

  Laveist, Thomas ^a   Gaskin, Darrell ^a   Richard, Patrick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST-BENEFIT ANALYSIS; ECONOMIC ANALYSIS; ESTIMATION METHOD; HEALTH SERVICES; MINORITY GROUP; MORTALITY; SURVEY;

ARTICLE; ECONOMICS; ETHICS; ETHNOLOGY; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH DISPARITY; HUMAN; LIFE EXPECTANCY; PRODUCTIVITY; SOCIAL JUSTICE; UNITED STATES;

EFFICIENCY; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LIFE EXPECTANCY; SOCIAL JUSTICE; UNITED STATES;

UNITED STATES;

EID: 79953204962     PISSN: 00207314     EISSN: 15414469     Source Type: Journal    
DOI: 10.2190/HS.41.2.c     Document Type: Article

References (30)

1. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academy Press, Washington, DC, 2002.
2. LaVeist, T. A. Minority Populations and Health: An Introduction to Health Disparities in the U.S. Jossey-Bass, San Francisco, 2005.
3. Agency for Healthcare Research and Quality. National Healthcare Disparities Report, 2006. Rockville, MD, 2006. http://www.ahrq.gov/qual/nhdr06/ nhdr06.htm
4. Franks, P., et al. The burden of disease associated with being African-American in the United States and the contribution of socio-economic status. Soc. Sci. Med. 62(10):2469-2478, 2006.
5. Trogdon, J. G., et al. The economic burden of chronic cardiovascular disease for major insurers. Health Promot. Pract. 8(3):234-242, 2007.
6. Doan, Q. V., et al. Economic burden of cardiovascular events and fractures among patients with end-stage renal disease. Curr. Med. Res. Opin. 23(7):1561-1569, 2007.
7. Insinga, R. P., Dasbach, E. J., and Elbasha, E. H. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus- related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics 23(11):1107-1122, 2005.
8. áInsinga, R. P., Glass, A. G., and Rush, B. B. The health care costs of cervical human papillomavirus-related disease. Am. J. Obstet. Gynecol. 191(1):114-120, 2004.
9. Fleurence, R. L., et al. Review of the economic and quality-of-life burden of cervical human papillomavirus disease. Am. J. Obstet. Gynecol. 196(3):206-212, 2007.
10. Hogan, P., Dall, T., and Nikolov, P. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diab. Care 26(3):917-932, 2003.
11. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diab. Care 21(2):296-309, 1998.
12. Ringel, J. S., and Sturm, R. Financial burden and out-of-pocket expenditures for mental health across different socioeconomic groups: Results from healthcare for communities. J. Ment. Health Policy Econ. 4(3):141-150, 2001.
13. Wu, E. Q., et al. The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry 66(9):1122-1129, 2005.
14. Greenberg, P. E., et al. The economic burden of depression in the United States: How did it change between 1990 and 2000? J. Clin. Psychiatry 64(12):1465-1475, 2003.
15. Finkelstein, E. A., Cosco, P. S., and Miller, T. R. The Incidence and Economic Burden of Injuries in the United States. Oxford University Press, New York, 2006.
16. Finkelstein, E. A., Fiebelkorn, I. C., and Wang, G. National medical spending attributable to overweight and obesity: How much, and who's paying? Health Aff. (Millwood), Suppl., Web Exclusives, W3-219-226, 2003.
17. Kortt, M. A., Langley, P. C., and Cox, E. R. A review of cost-of-illness studies on obesity. Clin. Ther. 20(4):772-779, 1998.
18. Yelin, E., et al. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: Total and incremental estimates. Arthritis Rheum. 50(7):2317-2326, 2004.
19. Yelin, E., et al. A national study of medical care expenditures for musculoskeletal conditions: The impact of health insurance and managed care. Arthritis Rheum. 44(5):1160-1169, 2001.
20. Noyes, K., et al. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov. Disord. 21(3):362-372, 2006.
21. Ryan, J., et al. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 24(47-48):6812-6822, 2006.
22. Hodgson, T. A., and Cohen, A. J. Medical care expenditures for selected circulatory diseases: Opportunities for reducing national health expenditures. Med. Care 37(10): 994-1012, 1999.
23. Dehkharghani, S., et al. The economic burden of skin disease in the United States. J. Am. Acad. Dermatol. 48(4):592-599, 2003.
24. Strassels, S. A. Economic consequences of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 5(2):100-104, 1999.
25. Rein, D. B., et al. The economic burden of major adult visual disorders in the United States. Arch. Ophthalmol. 124(12):1754-1760, 2006.
26. Cohen, J. W., et al. The Medical Expenditure Panel Survey: A national health information resource. Inquiry. 33:373-389, 1996/1997.
27. Heron, M. P., et al. Deaths: Final Data for 2006. National Vital Statistics Reports No. 57(14). National Center for Health Statistics, Hyattsville, MD, 2009.
28. Hirth, R. A., et al. Willingness to pay for a quality-adjusted life year: In search of a standard. Med. Decis. Mak. 20:332-342, 2000.
29. Braithwaite, R. S., et al. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med. Care 46:349-356, 2008.
30. World Bank. World Development Indicators Database, 1 July 2009, Gross Domestic Product. 2008. http://siteresources.worldbank.org/DATASTATISTICS/ Resources/GDP.pdf